Amy Israel, Senior Advisor, Access to Medicines at Union for International Cancer Control (UICC), shared a post on LinkedIn:
“It’s always the people. Energising. Inspiring. Relentless.
And this year’s ASCO 2026 delivered.
The researchers earning a standing ovation for daraxonrasib data showing a nearly doubled survival in pancreatic cancer. A disease that has long been a death sentence, finally yielding.
Dr Brian Wolpin said afterwards: ‘It felt like 20 years of work all rolled into 12 minutes.’
Check out the various videos of the standing ovation; it will give you goose bumps.
The practitioners trying to drive the science of implementation to address the care gap in the US.
The partners who attended our joint ASCO / ATOM Coalition session and shared solutions on improving access to critical cancer medicines in LMICs.
Thank you to the ASCO leadership, committees, and volunteers. Honoured to be part of this community.”
More posts featuring Amy Israel.
